Skip to content

Clinical Study on the Use of Massage to Reconstruct the Function of Lumbar Stabilizer Muscles and Improve the Muscle and Bone Imbalance of Lumbar Disc Herniation

Clinical Study on the Use of Massage to Reconstruct the Function of Lumbar Stabilizer Muscles and Improve the Muscle and Bone Imbalance of Lumbar Disc Herniation

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06946979
Enrollment
96
Registered
2025-04-27
Start date
2025-04-30
Completion date
2026-03-01
Last updated
2025-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation

Brief summary

1. .Characterization of Stabilizing Muscle Dysfunction in LDH Patients Using advanced techniques such as high-density surface electromyography (HD-sEMG), this study will investigate the functional imbalance of lumbar stabilizing muscles in LDH patients by comparing their muscle function indicators to those of healthy controls. 2. .Impact of Spinal Manipulation on Lumbar Stabilizing Muscle Function Through serial sEMG evaluations, the study will assess changes in stabilizing muscle function in LDH patients before and after spinal manipulation. This includes a focus on endurance, motor control, and reaction time, providing evidence to inform the application of spinal manipulation in LDH treatment. 3. .Exploration of Mechanisms Underlying Spinal Manipulation in Improving Musculoskeletal Imbalance The study will examine correlations between improvements in stabilizing muscle function and clinical symptoms, such as pain relief and functional recovery. Statistical analyses of sEMG data and clinical efficacy indicators will be conducted to uncover the therapeutic characteristics of spinal manipulation in LDH intervention, offering new theoretical bases and strategies for long-term treatment and recurrence prevention.

Interventions

OTHERSpinal Manipulation

Spinal Manipulation Therapy The treatment consists of two standardized steps: tendon adjustment techniques and bone-setting techniques. The total duration for both steps is approximately 15 minutes, conducted three times per week for two consecutive weeks.

OTHERMedication

Patients in both groups will receive celecoxib (one tablet, twice daily) for two weeks, with detailed records maintained.

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 1.Meet the diagnostic criteria for LDH as outlined in the ninth edition of Surgery, with confirmation via MRI; * 2.Age between 20 and 50; * 3.Simple L4/5 disc herniation; VAS score ≥30/100; * 4.Lumbar ODI index ≥20; * 5.No massage, acupuncture, or physical therapy within the past month; * 6.Signed informed consent form.

Exclusion criteria

* 1:

Design outcomes

Primary

MeasureTime frameDescription
Lumbar Stabilizer Muscle Function Indicators.week 3 (after the completion of the 2-week treatment period)Procedure: Patients lie prone on a table with the anterior superior iliac spine at the table edge. The upper body is suspended horizontally, arms crossed over the chest or extended parallel to the floor. Patients will maintain this posture for 90-120 seconds or until unable to continue (trunk angle deviation \> 5°-10°). Surface electromyography (sEMG) signals will be collected synchronously, with three repetitions averaged. Electrode Placement: Surface EMG (ME6000, Finland) will be used to collect sEMG signals. Electrodes (0.5 cm diameter, 2 cm spacing) will be placed at the L5-S1 level for multifidus (LM) and L4-L5 for erector spinae (LE) muscles. Reference electrodes will be positioned 3 cm laterally. Sampling rate is set at 1000 Hz, with a bandpass filter of 10-500 Hz and noise level \< 3.5 μV. Evaluation Metrics: Time-domain features and frequency-domain characteristics will be combined to report surface electromyography (sEMG) signals.

Secondary

MeasureTime frameDescription
Clinical efficacy indicators.week 3 (after the completion of the 2-week treatment period)Pain will be assessed using the Visual Analogue Scale (VAS) , internationally recognized metrics for evaluating clinical efficacy in pain . Measurements will be conducted pre-treatment and after two weeks of intervention.

Contacts

Primary Contactya Wen
20193060@zcmu.edu.cn15295519590

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026